APLS vs BIIB: Which Stock is Better?
Side-by-side comparison of Apellis Pharmaceuticals Inc and Biogen Inc in 2026
APLS
Apellis Pharmaceuticals Inc
$40.88
BIIB
Biogen Inc
$178.32
Key Metrics Comparison
| Metric | APLS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $5.22B | $26.26B | BIIB |
| P/E Ratio | 226.94 | 20.38 | BIIB |
| EPS (TTM) | $0.18 | $8.78 | BIIB |
| Revenue Growth | -0.1% | -0.1% | APLS |
| Gross Margin | 60.3% | 78.9% | BIIB |
Analyze APLS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APLS or BIIB a better investment?
Comparing APLS and BIIB: Apellis Pharmaceuticals Inc has a market cap of $5.22B while Biogen Inc has $26.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APLS and BIIB?
APLS (Apellis Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APLS or BIIB?
Based on P/E ratios, BIIB trades at a lower multiple (20.4x vs 226.9x).
Which is growing faster: APLS or BIIB?
APLS has higher revenue growth at -0.1% vs -0.1% for BIIB.
Which company is more profitable: APLS or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 60.3% for APLS.
Which is the larger company: APLS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.26B compared to $5.22B for APLS.
Should I buy APLS or BIIB in 2026?
Both APLS and BIIB have investment merit. APLS trades at $40.88 while BIIB trades at $178.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APLS and BIIB stock?
Key differences: Market Cap ($5.22B vs $26.26B), P/E Ratio (226.9x vs 20.4x), Revenue Growth (-0.1% vs -0.1%), Gross Margin (60.3% vs 78.9%).